|
Spectrum of activity:
|
Gram-positive
|
|
Details of activity:
|
Active against vancomycin-intermediate and -susceptible Staphylococcus aureus, Staphylococcus epidermidis, linezolid-resistant Staphylococcus aureus, vancomycin-resistant and -susceptible Enterococcus, linezolid-resistant Enterococcus, Streptococcus pneumoniae, and Clostridium difficile; protein synthesis inhibitor
|
|
Propensity to select resistant mutants:
|
Yes, low at <3x10^-10 at 4xMIC for methicillin-resistant Staphylococcus aureus
|
|
Description:
|
Synthetic compound; shows good bioavailability and low plasma clearance in mouse and rat
|
|
Institute where first reported:
|
Department of Microbiology, Daiichi Sankyo India Pharma Private Limited, Gurgaon, Haryana, India;
|
|
Year first mentioned:
|
2016
|
|
Development status:
|
Experimental
|